Kelly A Frazer

Title: The Innovative Contributions of Kelly A. Frazer

Introduction

Kelly A. Frazer is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of cancer diagnostics and treatment, holding a total of four patents. Her work focuses on innovative methods for early detection and treatment of ovarian cancer and other malignancies.

Latest Patents

Frazer's latest patents include an early ovarian cancer detection diagnostic test based on mRNA isoforms. This method employs probes and/or primers to detect specific RNA isoform transcripts, providing a crucial tool for early diagnosis. Another notable patent involves compositions and methods for cancer and cancer stem cell detection and elimination. This invention offers various approaches to inhibit or ablate cancer stem cells and addresses the action of double-stranded RNA-specific adenosine deaminases, or ADAR enzymes. Additionally, her work includes methods for treating conditions responsive to the inhibition of cell differentiation and self-renewal of dysfunctional cells, including leukemia and Chronic Myeloid Leukemia (CML). Furthermore, her inventions provide methods for measuring the effectiveness of treatments aimed at reducing leukemic stem cells.

Career Highlights

Frazer has worked with esteemed organizations such as the University of California and Perlegen Sciences, Inc. Her experience in these institutions has allowed her to develop and refine her innovative ideas in cancer research.

Collaborations

Some of her notable coworkers include Christian L. Barrett and Dennis A. Carson. Their collaborative efforts have contributed to advancing research in cancer diagnostics and treatment.

Conclusion

Kelly A. Frazer's innovative work in cancer detection and treatment exemplifies her commitment to improving healthcare outcomes. Her patents reflect her dedication to advancing medical science and providing new solutions for challenging health issues.